Phase IV study to assess the safety, efficacy and immunogenicity of MJ Pharma-BIOSULIN�® 30:70

Authors
Category Primary study
Registry of TrialsClinical Trials Registry - India
Year 2020
This article has no abstract
Epistemonikos ID: b9fe89f883d69cd5602d8a1268e9445c54412c02
First added on: Apr 08, 2025